Genital Herpes Virus (HSV-2) is Spreading in Women; CBCD Reviews Scientific Data
Industry: Health & Fitness
“Genital herpes … is currently rising in the female population of developed countries.” (1) CBCD reviews studies and recommends two natural herpes remedies.
New York (PRUnderground) July 3rd, 2014
“Infected with herpes virus? The CBCD recommends taking Novirin or Gene-Eden-VIR.” – John Evans, CBCD
More women are being infected by the genital herpes virus (HSV-2). According to Dr. Maroñas-Jimenez and colleagues, “Genital herpes, which was considered to be a minor sexually transmitted disease (STD) in the past in developing countries, is rapidly increasing.” (2) According to Dr. Kumar and colleagues, HSV-2 infection is more common in women (approximately one out of four women) than in men (almost one out of five). (3) Dr. Maroñas-Jimenez works at the Dermatology Department, 12 de Octubre University Hospital, Madrid, Spain. Dr. Kumar works at the Department of Dermatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
The Center for the Biology of Chronic Disease (CBCD) therefore recommends that man and women infected with the genital herpes virus (HSV-2) take Novirin or Gene-Eden-VIR. The formula of these natural antiviral products was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Gene-Eden-VIR and Novirin formula is effective against the herpes simplex virus (HSV), and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with the HSV … reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (4) The study authors also wrote that, “we observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (4)
Both products can be ordered online on the Novirin or Gene-Eden-VIR websites.
Novirin and Gene-Eden-VIR are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Novirin and Gene-Eden-VIR are the only natural antiviral products on the market with published clinical studies that support their claims.
Herpes rates are rising in other groups as well. “Race and ethnicity in the United States correlate with other, more fundamental determinants of health such as poverty, access to good quality health care, behavior for seeking health care, illicit drug use, and living in communities with a high prevalence of STDs. Since the late 1970s, the number of Americans with genital herpes infection has increased 30%. The largest increase is currently occurring in young white teens. HSV-2 infection is now five times more common in 12- to 19-year-old whites, and it is twice as common in young adults ages 20 to 29 than it was 20 years ago.” (3)
What treatments are available for herpes infections?
“Two types of antiviral treatments against HSV are available: topical and oral. The treatments include penciclovir, acyclovir, famciclovir, and valaciclovir. However, their effectiveness is limited. For instance, a meta-analysis of five placebo-controlled and two dose comparison studies evaluated the effect of aciclovir, famciclovir or valaciclovir on symptoms. The meta-analysis showed that oral antiviral therapy decreases the duration and the associated pain of an outbreak by merely one day.” (4) There are also natural antiviral products that studies show to be safe and effective in reducing herpes symptoms. Two of these products are Gene-Eden-VIR and Novirin.
Click to learn more about Novirin and herpes virus and Gene-Eden-VIR and herpes virus.
The papers that report the results of the clinical studies that tested the formula of Gene-Eden-VIR and Novirin are available on the CBCD website at https://cbcd.net/Gene-Eden-VIR-Clinical-Study.php and https://cbcd.net/Gene-Eden-VIR-Decreases-Fatigue-Clinical-Study.php.
References:
(1) Maroñas-Jimenez L, Menis D, Delgado-Márquez AM, Zarco-Olivo C, Ortiz de Frutos FJ. Primary herpes simplex infection with genital and extra-genital lesions mimicking disseminated gonococcal disease. Br J Dermatol. 2014 Jun 16. doi: 10.1111/bjd.13183 [Epub ahead of print]
(2) Kumar B, Sahoo B, Gupta S, Jain R. Rising incidence of genital herpes over two decades in a sexually transmitted disease clinic in north India. J Dermatol. 2002 Feb;29(2):74-8
(3) MedicineNet.com – Genital Herpes – On the Rise! Last reviewed in July 2004
(4) Polansky H, Itzkovitz E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Pharmacology & Pharmacy, 2013, 4, 1-8 https://dx.doi.org/10.4236/pp.2013.46A001
About CBCD
About CBCD
The Center for the Biology of Chronic Disease (https://www.cbcd.net) is a not-for-profit tax-exempt organization under section 501(c) 3 of the IRS tax code. The center’s mission is to advance the research on the biology of chronic disease and to accelerate the discovery of a cure for these diseases. The CBCD first published Dr. Hanan Polansky’s highly acclaimed “Purple” book, entitled “Microcompetition with Foreign DNA and the Origin of Chronic Disease” in 2003. In this book, he explains how foreign DNA fragments can cause many major diseases. The book has been read by more than 5,000 scientists around the world, and has been reviewed in more than 20 leading scientific journals. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
